Articles

Stem Cell Therapy: A Promising Approach for Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a multifaceted neurological condition that influences communication abilities, social engagement, and behavior. Traditional treatments—such as behavioral interventions, educational support, and medications—are primarily focused on managing symptoms rather than addressing underlying causes. However, stem cell therapy…

Read MoreStem Cell Therapy: A Promising Approach for Autism Spectrum Disorder

UC-MSC Stem Cell Therapy for Diabetic Foot Ulcers: A Regenerative Advancement in Wound Care Management

Diabetic foot ulcers (DFUs) are among the most complex and debilitating complications associated with diabetes mellitus, affecting up to 25% of patients during their lifetime. These chronic wounds are a leading cause of non-traumatic lower-extremity amputations worldwide. Despite advancements in…

Read MoreUC-MSC Stem Cell Therapy for Diabetic Foot Ulcers: A Regenerative Advancement in Wound Care Management

Advancing Treatment of Autism Spectrum Disorder with UC-MSC Stem Cell Therapy

Autism Spectrum Disorder (ASD) is a neurodevelopmental condition characterized by deficits in social communication, restricted interests, and repetitive behaviors. While its exact cause remains complex and multifactorial, involving genetic and environmental components, there remains a lack of curative treatments. Traditional…

Read MoreAdvancing Treatment of Autism Spectrum Disorder with UC-MSC Stem Cell Therapy

Restoring Metabolic Homeostasis: The Regenerative Role of UC-MSC Stem Cell Therapy in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus (T2DM) is a progressive metabolic disorder characterized by peripheral insulin resistance paired with the gradual failure of pancreatic . Current management strategies primarily biguanides, SGLT2 inhibitors, and exogenous insulin analogs excel at symptomatic glucose stabilization but fail…

Read MoreRestoring Metabolic Homeostasis: The Regenerative Role of UC-MSC Stem Cell Therapy in Type 2 Diabetes Mellitus

Therapeutic Applications of UC-MSC Stem Cells for Diabetic Foot Ulcers: A Regenerative Medicine Perspective

Diabetic foot ulcers (DFUs) are among the most prevalent and debilitating complications in individuals with diabetes mellitus. Affecting approximately 15–25% of patients during their lifetime, DFUs represent a leading cause of hospitalization and lower extremity amputation globally. Conventional treatments often…

Read MoreTherapeutic Applications of UC-MSC Stem Cells for Diabetic Foot Ulcers: A Regenerative Medicine Perspective

Advancing Diabetic Heel Ulcer Healing with UC-MSC Stem Cell Therapy: A Regenerative Medicine Approach

In the population with diabetes mellitus, diabetic heel ulcers are a serious medical concern. These chronic wounds, which are seen in the posterior plantar region, are commonly linked to pressure-induced trauma, ischaemia, and peripheral neuropathy. About 15% of diabetics will…

Read MoreAdvancing Diabetic Heel Ulcer Healing with UC-MSC Stem Cell Therapy: A Regenerative Medicine Approach

UC-MSC-Based Stem Cell Therapy for Chronic Ulcers: Advances Regenerative Solutions for Refractory Wounds

Chronic ulcers, which include pressure sores, venous leg ulcers, and ischaemic wounds, pose a substantial public health concern due to their lengthy healing duration and high recurrence rates. These lesions frequently afflict people who have comorbidities such vascular insufficiency, extended…

Read MoreUC-MSC-Based Stem Cell Therapy for Chronic Ulcers: Advances Regenerative Solutions for Refractory Wounds

Vega Stem Cell Becomes Official Distributor of DKSH’s Newly Approved Oral Sildenafil Drug “Please” in Thailand

Bangkok, Thailand – June 5, 2025 Vega Stem Cell is pleased to announce its appointment as one of the first official distributors of “Please,” a newly FDA-approved oral Sildenafil medication in Thailand, distributed by DKSH—a global leader in healthcare logistics.…

Read MoreVega Stem Cell Becomes Official Distributor of DKSH’s Newly Approved Oral Sildenafil Drug “Please” in Thailand

Regenerative Therapy for Diabetic Ulcers Using UC-MSC Stem Cells: A New Approach to the Treatment of Chronic Wounds

Chronic foot ulcers are a common and debilitating consequence of diabetes, particularly type 2. These lesions affect up to 25% of diabetes individuals and are a primary cause of lower-limb amputations worldwide. Because of the complex nature of diabetic wounds,…

Read MoreRegenerative Therapy for Diabetic Ulcers Using UC-MSC Stem Cells: A New Approach to the Treatment of Chronic Wounds

This website uses cookies to enhance your browsing experience and ensure the site functions properly. By continuing to use this site, you acknowledge and accept our use of cookies.

Accept All Accept Required Only